Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Assessment and determinants of whole blood and plasma fibrinolysis in patients with mild bleeding symptoms.

Vries MJA, Macrae F, Nelemans PJ, Kuiper GJAJM, Wetzels RJH, Bowman P, Verhezen PWM, Ten Cate H, Ariëns RAS, Henskens YMC.

Thromb Res. 2019 Feb;174:88-94. doi: 10.1016/j.thromres.2018.12.004. Epub 2018 Dec 4.

PMID:
30579151
2.

Preoperative screening for bleeding disorders: A comprehensive laboratory assessment of clinical practice.

Vries MJ, van der Meijden PE, Kuiper GJ, Nelemans PJ, Wetzels RJ, van Oerle RG, Lancé MD, Ten Cate H, Henskens YM.

Res Pract Thromb Haemost. 2018 Jul 27;2(4):767-777. doi: 10.1002/rth2.12114. eCollection 2018 Oct.

3.

Shifts of Transfusion Demand in Cardiac Surgery After Implementation of Rotational Thromboelastometry-Guided Transfusion Protocols: Analysis of the HEROES-CS (HEmostasis Registry of patiEntS in Cardiac Surgery) Observational, Prospective Open Cohort Database.

Kuiper GJAJM, van Egmond LT, Henskens YMC, Roekaerts PM, Maessen JG, Ten Cate H, Buhre WF, Lancé MD.

J Cardiothorac Vasc Anesth. 2019 Feb;33(2):307-317. doi: 10.1053/j.jvca.2018.08.203. Epub 2018 Aug 29.

4.

Platelet Aggregation in Healthy Participants is Not Affected by Smoking, Drinking Coffee, Consuming a High-Fat Meal, or Performing Physical Exercise.

Krekels JPM, Verhezen PWM, Henskens YMC.

Clin Appl Thromb Hemost. 2018 Jan 1:1076029618782445. doi: 10.1177/1076029618782445. [Epub ahead of print]

PMID:
29916260
5.

Impaired mitochondrial activity explains platelet dysfunction in thrombocytopenic cancer patients undergoing chemotherapy.

Baaten CCFMJ, Moenen FCJI, Henskens YMC, Swieringa F, Wetzels RJH, van Oerle R, Heijnen HFG, Ten Cate H, Holloway GP, Beckers EAM, Heemskerk JWM, van der Meijden PEJ.

Haematologica. 2018 Sep;103(9):1557-1567. doi: 10.3324/haematol.2017.185165. Epub 2018 Jun 7.

6.

The diagnostic accuracy of bleeding assessment tools for the identification of patients with mild bleeding disorders: A systematic review.

Moenen FCJI, Nelemans PJ, Schols SEM, Schouten HC, Henskens YMC, Beckers EAM.

Haemophilia. 2018 Jul;24(4):525-535. doi: 10.1111/hae.13486. Epub 2018 Jun 6. Review.

PMID:
29873431
7.

Direct oral anticoagulants: When to consider laboratory testing?

Ten Cate H, Olie RH, Ten Cate-Hoek AJ, Henskens YMC.

Int J Lab Hematol. 2018 May;40 Suppl 1:30-33. doi: 10.1111/ijlh.12816. Review.

PMID:
29741249
8.

Detecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillation.

Henskens YMC, Gulpen AJW, van Oerle R, Wetzels R, Verhezen P, Spronk H, Schalla S, Crijns HJ, Ten Cate H, Ten Cate-Hoek A.

Thromb J. 2018 Feb 1;16:3. doi: 10.1186/s12959-017-0160-2. eCollection 2018.

9.

Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis.

Spronk HMH, Padro T, Siland JE, Prochaska JH, Winters J, van der Wal AC, Posthuma JJ, Lowe G, d'Alessandro E, Wenzel P, Coenen DM, Reitsma PH, Ruf W, van Gorp RH, Koenen RR, Vajen T, Alshaikh NA, Wolberg AS, Macrae FL, Asquith N, Heemskerk J, Heinzmann A, Moorlag M, Mackman N, van der Meijden P, Meijers JCM, Heestermans M, Renné T, Dólleman S, Chayouâ W, Ariëns RAS, Baaten CC, Nagy M, Kuliopulos A, Posma JJ, Harrison P, Vries MJ, Crijns HJGM, Dudink EAMP, Buller HR, Henskens YMC, Själander A, Zwaveling S, Erküner O, Eikelboom JW, Gulpen A, Peeters FECM, Douxfils J, Olie RH, Baglin T, Leader A, Schotten U, Scaf B, van Beusekom HMM, Mosnier LO, van der Vorm L, Declerck P, Visser M, Dippel DWJ, Strijbis VJ, Pertiwi K, Ten Cate-Hoek AJ, Ten Cate H.

Thromb Haemost. 2018 Feb;118(2):229-250. doi: 10.1160/TH17-07-0492. Epub 2018 Jan 29.

10.

[Haemolysis: role of the direct antiglobulin test and eluate].

Hamer HM, Beckers EA, Henskens YM.

Ned Tijdschr Geneeskd. 2018;161:D1290. Dutch.

PMID:
29350115
11.

Practical guidance on the use of laboratory testing in the management of bleeding in patients receiving direct oral anticoagulants.

Ten Cate H, Henskens YM, Lancé MD.

Vasc Health Risk Manag. 2017 Dec 13;13:457-467. doi: 10.2147/VHRM.S126265. eCollection 2017. Review.

12.

The development of D antibodies after D-mismatched kidney transplantation in a setting of reduced immunosuppression.

Habets THPM, Vanderlocht J, Straat RJMHE, van Smaalen TC, Bos GMJ, Beckers EA, Christiaans MHL, Henskens YMC.

Transfusion. 2018 Jan;58(1):100-104. doi: 10.1111/trf.14405. Epub 2017 Nov 29.

PMID:
29193117
13.

Screening for platelet function disorders with Multiplate and platelet function analyzer.

Moenen FCJI, Vries MJA, Nelemans PJ, van Rooy KJM, Vranken JRRA, Verhezen PWM, Wetzels RJH, Ten Cate H, Schouten HC, Beckers EAM, Henskens YMC.

Platelets. 2017 Nov 14:1-7. doi: 10.1080/09537104.2017.1371290. [Epub ahead of print]

PMID:
29135309
14.

Routine haemostasis testing before transplanted kidney biopsy: a cohort study.

Kuiper GJAJM, Christiaans MHL, Mullens MHJM, Ten Cate H, Hamulýak K, Henskens YMC.

Transpl Int. 2018 Mar;31(3):302-312. doi: 10.1111/tri.13090. Epub 2017 Nov 21.

PMID:
29108097
15.

Empirically Reduced Dosages of Tinzaparin in Patients with Moderate-to-Severe Renal Insufficiency Lead to Inadequate Anti-Xa Levels.

Olie RH, Meertens NEL, Henskens YMC, Ten Cate H.

Nephron. 2017;137(2):113-123. doi: 10.1159/000477474. Epub 2017 Jun 30.

PMID:
28662505
16.

Application of an optimized flow cytometry-based quantification of Platelet Activation (PACT): Monitoring platelet activation in platelet concentrates.

Kicken CH, Roest M, Henskens YM, de Laat B, Huskens D.

PLoS One. 2017 Feb 16;12(2):e0172265. doi: 10.1371/journal.pone.0172265. eCollection 2017.

17.

The use of regression analysis in determining reference intervals for low hematocrit and thrombocyte count in multiple electrode aggregometry and platelet function analyzer 100 testing of platelet function.

Kuiper GJAJM, Houben R, Wetzels RJH, Verhezen PWM, Oerle RV, Ten Cate H, Henskens YMC, Lancé MD.

Platelets. 2017 Nov;28(7):668-675. doi: 10.1080/09537104.2016.1257782. Epub 2017 Jan 9.

PMID:
28067094
18.

Within-day biological variation and hour-to-hour reference change values for hematological parameters.

Hilderink JM, Klinkenberg LJJ, Aakre KM, de Wit NCJ, Henskens YMC, van der Linden N, Bekers O, Rennenberg RJMW, Koopmans RP, Meex SJR.

Clin Chem Lab Med. 2017 Jun 27;55(7):1013-1024. doi: 10.1515/cclm-2016-0716.

PMID:
28002028
19.

Determinants of agreement between proposed therapeutic windows of platelet function tests in vulnerable patients.

Vries MJ, Bouman HJ, Olie RH, Veenstra LF, Zwaveling S, Verhezen PW, Ten Cate-Hoek AJ, Ten Cate H, Henskens YM, van der Meijden PE.

Eur Heart J Cardiovasc Pharmacother. 2017 Jan;3(1):11-17. doi: 10.1093/ehjcvp/pvw026. Epub 2016 Sep 7.

PMID:
27609198
20.

Rapid and Correct Prediction of Thrombocytopenia and Hypofibrinogenemia with Rotational Thromboelastometry in Cardiac Surgery Reconsidered.

Kuiper GJ, Henskens YM.

J Cardiothorac Vasc Anesth. 2016 Dec;30(6):e55-e56. doi: 10.1053/j.jvca.2016.04.009. Epub 2016 Apr 12. No abstract available.

PMID:
27498262
21.

OC-08 - Multiple functional defects in platelets from thrombocytopenic cancer patients undergoing chemotherapy.

Baaten CC, Moenen FC, Henskens YM, Swieringa F, Wetzels R, van Oerle R, Ten Cate H, Beckers EA, Heemskerk JW, van der Meijden PE.

Thromb Res. 2016 Apr;140 Suppl 1:S171. doi: 10.1016/S0049-3848(16)30125-6. Epub 2016 Apr 8.

PMID:
27161680
22.

A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders.

Simeoni I, Stephens JC, Hu F, Deevi SV, Megy K, Bariana TK, Lentaigne C, Schulman S, Sivapalaratnam S, Vries MJ, Westbury SK, Greene D, Papadia S, Alessi MC, Attwood AP, Ballmaier M, Baynam G, Bermejo E, Bertoli M, Bray PF, Bury L, Cattaneo M, Collins P, Daugherty LC, Favier R, French DL, Furie B, Gattens M, Germeshausen M, Ghevaert C, Goodeve AC, Guerrero JA, Hampshire DJ, Hart DP, Heemskerk JW, Henskens YM, Hill M, Hogg N, Jolley JD, Kahr WH, Kelly AM, Kerr R, Kostadima M, Kunishima S, Lambert MP, Liesner R, López JA, Mapeta RP, Mathias M, Millar CM, Nathwani A, Neerman-Arbez M, Nurden AT, Nurden P, Othman M, Peerlinck K, Perry DJ, Poudel P, Reitsma P, Rondina MT, Smethurst PA, Stevenson W, Szkotak A, Tuna S, van Geet C, Whitehorn D, Wilcox DA, Zhang B, Revel-Vilk S, Gresele P, Bellissimo DB, Penkett CJ, Laffan MA, Mumford AD, Rendon A, Gomez K, Freson K, Ouwehand WH, Turro E.

Blood. 2016 Jun 9;127(23):2791-803. doi: 10.1182/blood-2015-12-688267. Epub 2016 Apr 15.

23.

Increased coagulation and fibrinolytic potential of solvent-detergent plasma: a comparative study between Omniplasma and fresh frozen plasma.

van Beers JJ, van Egmond LT, Wetzels RJ, Verhezen PW, Beckers EA, van Oerle R, Spronk HM, Straat RJ, Henskens YM.

Vox Sang. 2016 Jul;111(1):33-42. doi: 10.1111/vox.12395. Epub 2016 Feb 29.

PMID:
26927329
24.

Platelet Control of Fibrin Distribution and Microelasticity in Thrombus Formation Under Flow.

Swieringa F, Baaten CC, Verdoold R, Mastenbroek TG, Rijnveld N, van der Laan KO, Breel EJ, Collins PW, Lancé MD, Henskens YM, Cosemans JM, Heemskerk JW, van der Meijden PE.

Arterioscler Thromb Vasc Biol. 2016 Apr;36(4):692-9. doi: 10.1161/ATVBAHA.115.306537. Epub 2016 Feb 4.

PMID:
26848157
25.

Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity.

Kuiper GJ, Kleinegris MC, van Oerle R, Spronk HM, Lancé MD, Ten Cate H, Henskens YM.

Thromb J. 2016 Jan 14;14:1. doi: 10.1186/s12959-016-0076-2. eCollection 2016.

26.

Coated platelets function in platelet-dependent fibrin formation via integrin αIIbβ3 and transglutaminase factor XIII.

Mattheij NJ, Swieringa F, Mastenbroek TG, Berny-Lang MA, May F, Baaten CC, van der Meijden PE, Henskens YM, Beckers EA, Suylen DP, Nolte MW, Hackeng TM, McCarty OJ, Heemskerk JW, Cosemans JM.

Haematologica. 2016 Apr;101(4):427-36. doi: 10.3324/haematol.2015.131441. Epub 2015 Dec 31.

27.

Assessment of bleeding risk in patients with coronary artery disease on dual antiplatelet therapy. A systematic review.

Vries MJ, van der Meijden PE, Henskens YM, ten Cate-Hoek AJ, ten Cate H.

Thromb Haemost. 2016 Jan;115(1):7-24. doi: 10.1160/TH15-04-0355. Epub 2015 Aug 13. Review.

PMID:
26272731
28.

Gradual increase in thrombogenicity of juvenile platelets formed upon offset of prasugrel medication.

Baaten CC, Veenstra LF, Wetzels R, van Geffen JP, Swieringa F, de Witt SM, Henskens YM, Crijns H, Nylander S, van Giezen JJ, Heemskerk JW, van der Meijden PE.

Haematologica. 2015 Sep;100(9):1131-8. doi: 10.3324/haematol.2014.122457. Epub 2015 Jun 25.

29.

Effects of ultrapure hemodialysis and low molecular weight heparin on the endothelial surface layer.

Cornelis T, Broers NJ, Titulaer DC, Henskens YM, van Oerle R, van der Sande FM, Spronk HM, Vink H, Leunissen KM, ten Cate H, Kooman JP.

Blood Purif. 2014;38(3-4):203-10. doi: 10.1159/000369055. Epub 2014 Dec 16.

PMID:
25531879
30.

[Von Willebrand factor and Von Willebrand disease].

Verhezen PW, Beckers EA, Henskens YM.

Ned Tijdschr Geneeskd. 2014;158:A6885. Dutch.

PMID:
24800797
31.

Rapid and correct prediction of thrombocytopenia and hypofibrinogenemia with rotational thromboelastometry in cardiac surgery.

Olde Engberink RH, Kuiper GJ, Wetzels RJ, Nelemans PJ, Lance MD, Beckers EA, Henskens YM.

J Cardiothorac Vasc Anesth. 2014 Apr;28(2):210-6. doi: 10.1053/j.jvca.2013.12.004.

PMID:
24630470
32.

Peri-partum reference ranges for ROTEM(R) thromboelastometry.

de Lange NM, van Rheenen-Flach LE, Lancé MD, Mooyman L, Woiski M, van Pampus EC, Porath M, Bolte AC, Smits L, Henskens YM, Scheepers HC.

Br J Anaesth. 2014 May;112(5):852-9. doi: 10.1093/bja/aet480. Epub 2014 Jan 31.

33.

Long-term strenuous exercise induces a hypercoagulable state through contact activation.

Posthuma JJ, Loeffen R, van Oerle R, Henskens YM, ten Cate H, Spronk HM, van der Meijden PE.

Thromb Haemost. 2014 Jun;111(6):1197-9. doi: 10.1160/TH13-11-0963. Epub 2014 Jan 30. No abstract available.

PMID:
24477547
34.

Effect of pneumatic tube transport on rotational thromboelastometry.

Lancé MD, Henskens YM.

Br J Anaesth. 2013 Jan;110(1):142. doi: 10.1093/bja/aes439. No abstract available.

35.

Triple red blood cell alloantibody formation after bone-allograft transplantation.

Prinzen L, Staal HM, Rouwette SJ, Beckers EA, ten Broeke RH, van Rhijn LW, Henskens YM.

Am J Transplant. 2013 Jan;13(1):229-31. doi: 10.1111/j.1600-6143.2012.04300.x. Epub 2012 Oct 24.

36.

Mean platelet volume as a diagnostic marker for cardiovascular disease: drawbacks of preanalytical conditions and measuring techniques.

Lancé MD, Sloep M, Henskens YM, Marcus MA.

Clin Appl Thromb Hemost. 2012 Nov;18(6):561-8. doi: 10.1177/1076029612458147. Epub 2012 Aug 30. Review.

PMID:
22936787
37.

Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage.

de Lange NM, Lancé MD, de Groot R, Beckers EA, Henskens YM, Scheepers HC.

Obstet Gynecol Surv. 2012 Jul;67(7):426-35. doi: 10.1097/OGX.0b013e3182605861. Review.

PMID:
22926249
38.

Do blood collection methods influence whole-blood platelet function analysis?

Lancé MD, Henskens YM, Nelemans P, Theunissen MH, Oerle RV, Spronk HM, Marcus MA.

Platelets. 2013;24(4):275-81. doi: 10.3109/09537104.2012.689038. Epub 2012 May 30.

PMID:
22646490
39.

The effects of pneumatic tube system transport on ROTEM analysis and contact activation assessed by thrombin generation test.

Lancé MD, Kuiper GJ, Sloep M, Spronk HM, van Oerle R, ten Cate H, Marcus MA, Henskens YM.

Thromb Res. 2012 Sep;130(3):e147-50. doi: 10.1016/j.thromres.2012.05.002. Epub 2012 May 25.

PMID:
22633532
40.

Platelet concentrate transport in pneumatic tube systems--does it work?

Lancé MD, Marcus MA, van Oerle R, Theunissen HM, Henskens YM.

Vox Sang. 2012 Jul;103(1):79-82. doi: 10.1111/j.1423-0410.2011.01580.x. Epub 2012 Jan 5.

PMID:
22220640
41.

Mean platelet volume analysis needs more standardization.

Lance MD, Henskens YM, Marcus MA.

Platelets. 2011;22(3):241. doi: 10.3109/09537104.2010.529521. Epub 2010 Dec 8. No abstract available.

PMID:
21142406
42.

Do we need time adjusted mean platelet volume measurements?

Lancé MD, van Oerle R, Henskens YM, Marcus MA.

Lab Hematol. 2010 Sep;16(3):28-31. doi: 10.1532/LH96.10011.

PMID:
20858586
43.

Acute effects of hemodialysis on salivary flow rate and composition.

Bots CP, Brand HS, Veerman EC, Valentijn-Benz M, Henskens YM, Valentijn RM, Vos PF, Bijlsma JA, Ter Wee PM, Van Amerongen BM, Nieuw Amerongen AV.

Clin Nephrol. 2007 Jan;67(1):25-31.

PMID:
17269596
44.

Detection of imported malaria with the Cell-Dyn 4000 hematology analyzer.

Wever PC, Henskens YM, Kager PA, Dankert J, van Gool T.

J Clin Microbiol. 2002 Dec;40(12):4729-31.

45.

Salivary cystatin activity and cystatin C in natural and experimental gingivitis in smokers and non-smokers.

Lie MA, Loos BG, Henskens YM, Timmerman MF, Veerman EC, van der Velden U, van der Weijden GA.

J Clin Periodontol. 2001 Oct;28(10):979-84.

PMID:
11686817
46.

Cystatin A in gingival crevicular fluid of periodontal patients.

Blankenvoorde MF, Henskens YM, van der Weijden GA, van den Keijbus PA, Veerman EC, Nieuw Amerongen AV.

J Periodontal Res. 1997 Oct;32(7):583-8.

PMID:
9401930
47.

Inhibition of the growth and cysteine proteinase activity of Porphyromonas gingivalis by human salivary cystatin S and chicken cystatin.

Blankenvoorde MF, Henskens YM, van't Hof W, Veerman EC, Nieuw Amerongen AV.

Biol Chem. 1996 Dec;377(12):847-50.

PMID:
8997496
48.

Salivary protein composition in epileptic patients on different medications.

Henskens YM, Strooker H, van den Keijbus PA, Veerman EC, Nieuw Amerongen AV.

J Oral Pathol Med. 1996 Aug;25(7):360-6.

PMID:
8890049
49.

Effect of periodontal treatment on the protein composition of whole and parotid saliva.

Henskens YM, van der Weijden FA, van den Keijbus PA, Veerman EC, Timmerman MF, van der Velden U, Amerongen AV.

J Periodontol. 1996 Mar;67(3):205-12.

PMID:
8708950
50.

Cystatins in health and disease.

Henskens YM, Veerman EC, Nieuw Amerongen AV.

Biol Chem Hoppe Seyler. 1996 Feb;377(2):71-86. Review.

PMID:
8868064

Supplemental Content

Loading ...
Support Center